B9P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NovaBay Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.8 EUR Market Closed

Market Cap: €11.8m

	NovaBay Pharmaceuticals Inc F:B9P	US
E	Engie SA DUS:GZF	FR
I	Infineon Technologies AG MIL:IFX	DE
	Nordson Corp NASDAQ:NDSN	US
	Telefonaktiebolaget LM Ericsson STO:ERIC B	SE

Profitability Summary

NovaBay Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

46%

Negative Operating Margin

-937%

Negative 3Y Average Operating Margin

-156%

Declining Operating Margin

-97% > -937%

Negative Net Margin

-5 722%

Negative 3Y Average Net Margin

-684%

Declining Net Margin

-126% > -5 722%

Exceptional Free Cash Flow Margin

519%

Strong 3Y Average Free Cash Flow Margin

28%

Free Cash Flow Margin is Increasing

-44% > 519%

Exceptional ROE

260%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-147%

Declining ROIC

-100% > -306%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.